ArticleTrials2022

Noradrenergic Add-on Therapy with Extended-Release Guanfacine in Alzheimer's Disease (NorAD): study protocol for a randomised clinical trial and COVID-19 amendments.

Karen Hoang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.